Acute Management of Peripheral Arterial Thrombosis
Immediate anticoagulation with heparin followed by urgent revascularization (surgical or catheter-directed thrombolysis) is the cornerstone of acute peripheral arterial thrombosis management, with the specific approach determined by limb viability and whether the occlusion is embolic versus thrombotic in nature.
Initial Assessment and Immediate Intervention
Immediate Anticoagulation
- Start systemic heparinization immediately upon diagnosis to prevent thrombus propagation and improve microvascular perfusion 1, 2
- Heparin is indicated as a bridge to definitive therapy but is not a substitute for necessary operative intervention 1
Differentiate Embolic vs. Thrombotic Occlusion
- Arterial embolism (typically in patients with atrial fibrillation or recent MI) presents with sudden onset in a previously normal limb and carries 11% mortality due to underlying cardiac disease 1
- Acute thrombosis (superimposed on chronic atherosclerotic disease) often has preceding claudication symptoms, collateral vessels on exam, and lower mortality (3%) 1, 2
- Obtain preoperative angiography when feasible to guide treatment strategy 1
Treatment Strategy Based on Limb Viability
Immediately Threatened Limb (Profound Ischemia)
- Proceed directly to emergency surgical revascularization with thromboembolectomy 3, 4
- Completion angiography is mandatory to ensure adequate flow restoration 1
- For embolic occlusions, simple thrombectomy is usually sufficient 1
- For acute thrombotic occlusions, thrombectomy alone is inadequate—requires bypass grafting or additional revascularization of underlying stenotic lesions 1
Viable Limb (Not Immediately Threatened)
- Catheter-directed thrombolysis is the preferred initial approach for acute thrombosis when the limb remains viable 3, 5, 4
- Thrombolysis allows angiographic definition of underlying lesions and facilitates subsequent targeted percutaneous or surgical intervention 3, 4
- Continue heparin therapy during thrombolysis 2
- Warning: Severe bleeding occurs in a significant minority, with 1-2% risk of intracranial hemorrhage 3
Recent Acute Thrombosis with Viable Limb
- Long-term heparin therapy without immediate operation may be appropriate for very recent thrombosis (hours) with a clearly viable limb 1
- This approach is NOT suitable for embolic occlusions, which require prompt surgical intervention 1
Post-Revascularization Management
Antithrombotic Therapy
- Following lower-limb revascularization, use combination rivaroxaban 2.5 mg twice daily plus aspirin 100 mg daily in patients without high bleeding risk 6
- For patients with high bleeding risk: use dual antiplatelet therapy (DAPT) for 1-3 months, then transition to single antiplatelet therapy 6
- Long-term DAPT beyond 1 month is not recommended 6
High Bleeding Risk Criteria
High bleeding risk includes: dialysis or GFR <15 mL/min/1.73 m², acute coronary syndrome within 30 days, history of intracranial hemorrhage, stroke or TIA, or active bleeding 6
Critical Pitfalls to Avoid
- Do not rely on heparin alone as definitive treatment for arterial embolism—this produces inferior outcomes compared to prompt embolectomy 1
- Do not perform thrombectomy alone for acute atherosclerotic thrombosis—the underlying stenotic lesion must be addressed 1
- Do not skip completion angiography after any revascularization procedure 1
- Recognize that embolic occlusions are more dangerous than thrombotic due to associated severe cardiac pathology requiring concurrent management 1
Multidisciplinary Approach
Patients with chronic limb-threatening ischemia (CLTI) should be managed by a vascular team for optimal limb salvage outcomes 6, 7